The Horizons Tracker

MAY 2, 2023

The potential for social mobility was far from even across different industries, however, with sectors like finance, real estate, and insurance scoring particularly poorly. “We argue that CEOs’ social class can only be understood when considering both family background and the current resources (income and education) at their disposal.”

Class 109

Class CEO Education Engineering 109

Marshall Goldsmith

FEBRUARY 8, 2018

Co-founder of Rose Park Advisors—Disruptive Innovation Fund. A leading thinker on strategy and breakthrough innovation. Formerly a leader in the automotive, retail, restaurant, media innovation and consulting industries. Darek Lenart – Senior VP HR, Finance MasterCard. Leading innovator in HR for over 25 years.

Executive Coaching 70

Executive Coaching CEO Magazine Banking 70

Harvard Business Review

JUNE 9, 2017

How the most innovative providers are creating value. Equally troublesome, almost all policies focus exclusively on payments and finances but ignore the powerful influence of careerism and other non-financial motives that may compromise objectivity far more than financial incentives. Insight Center. Sponsored by Optum.

Conflict of Interest 8

Conflict of Interest Pharmaceuticals Policies Industry 8

Harvard Business Review

APRIL 2, 2018

To be sure, many factors influence health outcomes and the investments the health care system makes are only one input. But, like pharmaceuticals, each of these entities is represented by powerful lobbyists (such as physician and hospital organizations), who will strongly oppose any steps to reduce payments. For instance, the U.S.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

MAY 26, 2014

Four dynamics are driving this new era of health care innovation: Finally, there is a financial incentive to innovate. Top-tier thinkers from data science, business, finance, and the digital world are coming together to find new solutions. The intelligent use of data will have a transformative influence on all points of care.

Health Care 8

Health Care Venture Funding Entrepreneur Pharmaceuticals 8

Harvard Business Review

OCTOBER 13, 2011

The pharmaceutical industry also creates products with complex interactions and potentially dangerous side effects. Yet unlike in finance, where distributing risk across institutions is the goal, in drug development the focus is on isolating risk. Here, the protocols from other industries can provide some insight.

Banking 10

Banking Pharmaceuticals Microfinance Risk Management 10

Harvard Business Review

NOVEMBER 20, 2015

Corporate procurement processes are opaque, secretive, and can be influenced by political pull as well as pure performance. In the clubby world of pharmaceutical purchasing executives, PACIV’s reputation for transparency spread, setting a higher bar that his competitors begrudgingly were now asked to jump over.

Supply Chain 8

Supply Chain Collins Golden Handcuff Pharmaceuticals 8